Results 41 to 50 of about 77,862 (256)

FEATURES OF IMMUNE RESPONSE AND BASOPHIL ACTIVATION IN CHILDREN WITH CHRONIC URTICARIA

open access: yesМедицинская иммунология, 2015
Some features of peripheral bood basophil activation were studied in children with different types of chronic urticaria, in order to specify the sustaining mechanisms of chronic urticaria.
N. A. Sinelnikova   +2 more
doaj   +1 more source

Urticaria and infections

open access: yesAllergy, Asthma & Clinical Immunology, 2009
Urticaria is a group of diseases that share a distinct skin reaction pattern. Triggering of urticaria by infections has been discussed for many years but the exact role and pathogenesis of mast cell activation by infectious processes is unclear.
Wedi Bettina   +3 more
doaj   +1 more source

The Prevalence of Atopic Dermatitis and Chronic Spontaneous Urticaria are Associated with Parental Socioeconomic Status in Adolescents in China

open access: yesActa Dermato-Venereologica, 2018
The association of atopic dermatitis and chronic spontaneous urticaria with socioeconomic status has been little studied. The aim of this study was to investigate the prevalence of skin diseases and their association with socioeconomic status in ...
Yi Xiao   +15 more
doaj   +1 more source

Pharmacotherapy of chronic spontaneous urticaria

open access: yesExpert Opinion on Pharmacotherapy, 2013
Urticaria, by definition, is a disease presenting with wheals, angioedema or both. In patients with recurrent angioedema without wheals, urticaria needs to be distinguished from bradykinin-mediated angioedema, for example, hereditary angioedema or ACE inhibitor-induced angioedema.Urticaria is comprised of acute and chronic forms.
Makris, M., Maurer, M., Zuberbier, T.
openaire   +3 more sources

Treatment of Chronic Spontaneous Urticaria [PDF]

open access: yesAllergy, Asthma & Immunology Research, 2012
Chronic spontaneous urticaria is defined as persistent symptoms of urticaria for 6 weeks or more. It is associated with autoimmunity in approximately 45 percent of patients. Therapy is often difficult however the initial approach should employ high-dose non-sedating antihistamines; 4-6 tablets/day may be necessary.
openaire   +2 more sources

Biologic drugs in chronic spontaneous urticaria.

open access: yesActa bio-medica : Atenei Parmensis, 2021
Chronic spontaneous urticaria (CSU) is a condition defined by the presence of recurrent urticaria, angioedema, or both, which persist for more than six weeks in duration and occurs in the absence of an identifiable trigger. Both children and adults can develop CSU, although it is more common in adults and in women than in men, with a peak occurrence in
Licari A.   +9 more
openaire   +3 more sources

Type D Personality Is Associated with Poorer Quality of Life in Patients with Chronic Spontaneous Urticaria: A Cross-sectional Study

open access: yesActa Dermato-Venereologica, 2022
Type D personality (TDp) is a stable personality type that has been associated with poor quality of life in the general population and in patients with a variety of diseases, such as cancer, cardiac diseases, and dermatological diseases (e.g. psoriasis).
Manuel Sánchez-Díaz   +3 more
doaj   +1 more source

Anti‐KIT Barzolvolimab for Chronic Spontaneous Urticaria

open access: yesAllergy. European Journal of Allergy and Clinical Immunology
Chronic spontaneous urticaria (CSU) is characterized by mast cell (MC)‐mediated wheals and/or angioedema without identifiable triggers and is driven by MC activation.
M. Maurer   +11 more
semanticscholar   +1 more source

Differential Diagnosis of Chronic Spontaneous Urticaria [PDF]

open access: yesThe Journal of Allergy and Clinical Immunology: In Practice
Patients with chronic recurrent wheals most commonly receive the diagnosis of chronic spontaneous urticaria, although a number of autoimmune, autoinflammatory, and malignant diseases can be suspected based on certain red flags. These warning signs are a wheal duration of more than 24 hours, post-inflammatory hyperpigmentation, and systemic symptoms ...
Gialama, Dimitra   +7 more
openaire   +2 more sources

CT‐P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized, Active‐Controlled, Phase 3 Study

open access: yesAllergy. European Journal of Allergy and Clinical Immunology
This study compared the therapeutic equivalence of CT‐P39 (an omalizumab biosimilar) and EU‐approved reference omalizumab (ref‐OMA) in patients with chronic spontaneous urticaria.
Sarbjit S. Saini   +16 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy